Peter Valent (2011) “On the safety of low-dose dasatinib in comorbid and non-comorbid patients: what is real-life? (Reply)”, Haematologica. Pavia, Italy, 96(4), pp. e25-e25. doi: 10.3324/haematol.2011.041608.